K-26, a novel inhibitor of angiotensin I converting enzyme produced by an actinomycete K-26

44Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

A novel inhibitor of angiotensin I converting enzyme (ACE), designated K-26, was isolated from the broth filtrate of an actiomycete K-26. K-26 is a water soluble, acidic peptide composed of an equal mol of L-isoleucine, L-tyrosine and l(R)-l-amino-2-(4-hydroxyphenyl)-ethylphosphonic acid. The IC50 of K-26 for ACE inhibition was 6.7 ng/ml when hippuryl-L-histidyl-L-leucine was used as a substrate of ACE. K-26 possesses hypotensive activity in vivo. © 1986, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Yamato, M., Koguchi, T., Okachi, R., Yamada, K., Nakayama, K., Kase, H., … Shuto, K. (1986). K-26, a novel inhibitor of angiotensin I converting enzyme produced by an actinomycete K-26. The Journal of Antibiotics, 39(1), 44–52. https://doi.org/10.7164/antibiotics.39.44

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free